Durand's concerns began soon after he joined: He asked to meet TAP's in-house counsel and was told the company didn't have one. Some 10 months later, he began documenting fraud at TAP.
WHAT HE FOUND
Sales reps for TAP's drug Lupron had offered every urologist in the country a big-screen TV. Worse, they handed out Lupron at cut-rate prices or gratis while inflating the Medicare-reimbursement price.
In 2001, the federal government won an $875 million judgment against TAP. Four doctors pleaded guilty to fraud and await sentencing. Six TAP execs and one doctor face trial for conspiracy to commit fraud.